title: Role of endogenous CCK in the inhibition of gastric emptying by peptone and Intralipid in rats.
abstract: To assess the role of endogenous cholecystokinin in the control of gastric emptying of peptone solutions and Intralipid suspensions, we examined the ability of a dose range of the CCK-A antagonist, devazepide to accelerate the gastric emptying of various caloric concentrations of peptone and Intralipid in rats. In the absence of devazepide, both peptone and Intralipid emptying slowed with increasing concentration. Devazepide's effect on peptone gastric emptying diminished with increasing peptone concentration. The threshold dose for accelerating the emptying of 0.2 kcal/ml peptone was lower than the threshold dose for affecting 0.5 kcal/ml peptone and devazepide had no effect on the gastric emptying of 1.0 kcal/ml peptone. In contrast, devazepide affected Intralipid gastric emptying at all three Intralipid concentrations and the threshold dose decreased with increasing Intralipid concentration. However, the magnitude of the effect of devazepide on peptone or Intralipid gastric emptying was partial and did not increase as a function of concentration. These data demonstrate a role for endogenous CCK in the emptying of peptone and Intralipid but suggest that endogenous CCK does not account for the increased slowing of gastric emptying evident with increased caloric concentration.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618 720 Rutland Avenue, Baltimore, MD 21205, USA.
authors.forename: W O
authors.initials: WO
authors.lastname: White
authors.forename: G J
authors.initials: GJ
authors.lastname: Schwartz
authors.forename: T H
authors.initials: TH
authors.lastname: Moran
mesh_terms: D000818:Animals; D002766:Cholecystokinin / Q000037:antagonists & inhibitors*; D020109:Devazepide / Q000494:pharmacology; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D005746:Gastric Emptying / Q000187:drug effects* / Q000502:physiology; D006727:Hormone Antagonists / Q000494:pharmacology; D008297:Male; D010461:Peptones / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D005217:Fat Emulsions, Intravenous; D006727:Hormone Antagonists; D010461:Peptones; D002766:Cholecystokinin; D020109:Devazepide